Robert M. DiSogra

Robert M. DiSogra

Robert M. DiSogra, AuD, is an audiology consultant in Millstone, New Jersey. He currently holds two faculty positions at the Department of Audiology, University of the Pacific, San Francisco, CA (USA) and at the Department of Communication Sciences and Deafness, Kean University, Hillside, New Jersey. For over 25 years he has published, taught, and lectured extensively about pharmacology issues as they relate to the practice of audiology. Address all correspondence: 7 Nurko Rd., Millstone, NJ 08535; email: bobd1030@aol.com; website.

Coronavirus and combative medication image

ONLINE FEATURE | Audiological Management of COVID-19 Survivors Treated with Hydroxychloroquine and Azithromycin

In an effort to combat the coronavirus (COVID-19), front-line physicians are re-purposing two drugs: hydroxychloroquine (commonly used for malaria and rheumatoid arthritis) and azithromycin (a macrolide antibiotic used to treat common infections of the respiratory system, the ear and the eye). Both drugs are known ototoxic agents; however, there is no published research about the synergistic ototoxic effects of these drugs in treating COVID-19. 

Topic(s): COVID-19, Ototoxicity, Hydroxychloroquine, Azithromycin

Author(s): 

Publication Issue: Audiology Today May/June 2020